A single dose of the HPV vaccine can strengthen immune memory in people who’ve previously been infected with HPV — and potentially help prevent re-infection
Aug. 10, 2016
| By Sabrina Richards / Fred Hutch News Service
It’s long been known that the vaccine against the human papilloma virus offers protection when administered to those who’d never experienced HPV infection. But new research suggests the possibility that it could also help those who’d been previously infected to guard against re-infection, according to results recently published in EBioMedicine.
Stigma, isolation and medical complexity may keep patients from getting all the care they need; recommendations aim to change that
April 8, 2016
| By Diane Mapes and Sabrina Richards / Fred Hutch News Service
Head-and-neck cancer survivors can have enormous aftereffects from the disease and its treatment. New survivorship guidelines just released by the American Cancer Society should help them get the support they need.
Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care; Hutch study finds CMV viral load can act as surrogate endpoint for clinical trials; A new target for Tumor Paint: BLZ-100 lights up head and neck cancers; Dr. Stephen Tapscott appointed to NIAMS advisory council
Treatment could shrink tumors before surgery and reduce chemotherapy’s damaging side effects; clinical trial to launch later this year
Aug. 13, 2014
| By Dr. Rachel Tompa / Fred Hutch News Service
Using a technique that looks for genes that tumor cells need to survive, Fred Hutchinson Cancer Research Center scientists have identified a potential new drug for a class of difficult-to-treat head and neck cancers.